Your brand assets weren’t built for AI. Let’s talk about what’s next.

The DHC Forum at BAYER

A complimentary, invite-only executive DHC Forum for pharmaceutical marketers and industry thought leaders.

Three conversations every marketing leader is having right now, in one afternoon.

Request a Seat Limited capacity · Pharma marketers and DHC Network members

On the table

  1. 01The future of brand assets and AI (GEO)
  2. 02In-housing and structuring for data and media innovation
  3. 03The state of AI in pharma data, marketing, and media

 

Event Date

November 5, 2026

 

Event Location

Bayer HQ · Whippany, NJ

On the agenda

On November 5, the DHC Group convenes pharmaceutical brand, media, and data leadership at Bayer HQ (Whippany, NJ) for candid, in-room thought leadership. This isn’t a keynote. Every seat at the table is filled by someone shaping the industry’s next move.

The way customers find, judge, and engage with your brand is changing faster than your brand guidelines can keep up.

HCPs and patients increasingly meet your brand through AI-generated answers, summaries, and recommendations you don’t directly control. Media and data models built for the last decade are straining. And every team is being asked the same question from the top: what’s our AI plan, and what’s it delivering?

The Future of the Brand.com. What role the brand site plays as AI answers reshape discovery. Includes new research from DHCG, Google and CMI.

In-Housing and Structuring for Innovation. How leaders are organizing data and media capabilities, and what to own versus outsource.

Where AI Is Driving Value Today. Where AI is delivering results now across HCP and patient marketing.

Insights from market leaders at…

Bayer logo ''

Come for a conversation with peers…
past forums have been attended by…

  • AbbVie
  • Alnylam
  • Alora Pharmaceuticals
  • AstraZeneca
  • Axsome
  • Bayer
  • BeOne Medicines
  • Biogen
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • Esperion
  • GSK
  • Innoviva Specialty Therapeutics
  • Ipsen
  • Johnson & Johnson
  • Legend Biotech
  • Menarini Stemline
  • Moderna
  • Novartis
  • Novo Nordisk
  • Otsuka
  • Pfizer
  • Sanofi
  • Sun Pharma
  • Superluminal Medicines
  • Supernus
  • Teva Pharmaceuticals
  • UCB
  • ViiV Healthcare

REQUEST A SEAT

Leading the Discussion

This is a working session, with everyone in the room contributing to the discussion. Facilitators include:

Mark Bard
DHC Group

Stef Klaskow
Google

Glenniss Richards
Bayer

Sargi Mann
CMI Media Group

Stay Ahead With
the DHCG Newsletter.

Get periodic research updates, event invitations, exclusive interviews, and industry insights from our thought leaders.

* indicates required
""